Abstract
BackgroundProtein tyrosine phosphatase 1B (PTP1B) is one of the major negative regulators of leptin and insulin signaling, and has been strongly implicated in insulin resistance development in the course of obesity and metabolic syndrome conditions; however, its exact role in controlling adipose tissue biogenesis is still poorly understood.ObjectivesThis investigation aimed to elucidate whether selective inhibition of PTP1B using MSI-1436 compound may improve and restore the defective adipogenicity of ASCs isolated from EMS-affected horses.MethodsEquine ASC EMS cells were cultured under adipogenic conditions in the presence of PTP1B inhibitor and were subsequently tested for expression of the main adipogenic-related genes using RT-qPCR, changes in free fatty acid profiles by means of GC-MS technique, and for mitochondrial dynamics improvement through the analysis of mitochondrial transmembrane potential and oxidative stress.ResultsSelective inhibition of PTP1B in equine ASC EMS cells improved substantially adipogenic differentiation by promoting cellular proliferation and normalizing expression of C/EBPalpha, PPARγ, and Adipoq markers that are critical for proper adipogenesis. Levels of secreted adiponectin and PPARγ were also shown to be increased in MSI-1436-conditioned cells, while total leptin levels markedly dropped under the same conditions. Moreover, MSI-1436 treatment enabled the regulation of metabolic-related transcripts that are crosslink to adipogenesis, namely Akt1, Akt2, and SHBG. The obtained results demonstrated also an obvious reduction in intracellular accumulated ROS and NO, as well as mitigated ER stress through the downregulation of Chop, Perk, Atf6, Ire1, and Xbp1 transcripts upon PTP1B inhibition. Furthermore, general fluctuations in FFA composition of all differentiated groups have been highlighted, where palmitic acid, palmitoleic acid, stearic acid, and linolelaidic acid that are known to be associated with the development of metabolic disorders were found to be normalized upon PTP1B inhibition during adipogenic differentiation.ConclusionThe presented data provides the evidence that the use of PTP1B inhibitor may be successful in controlling and enhancing adipogenic differentiation of impaired equine ASCs affected by metabolic syndrome, and thus offers new insights for the management of obesity through the regulation of adipose tissue dynamics.Graphical abstract
Highlights
Protein tyrosine phosphatase 1B (PTP1B) is one of the major negative regulators of leptin and insulin signaling, and has been strongly implicated in insulin resistance development in the course of obesity and metabolic syndrome conditions; its exact role in controlling adipose tissue biogenesis is still poorly understood
We have found that equine metabolic syndrome (EMS) cells displayed decreased proliferation rate in both Undifferentiated cells (ND) and adipogenic differentiation (AD) conditions which stands with a good agreement with our and other studies, which showed that metabolically impaired cells suffer from decreased proliferation potential [18, 20, 21]
Selective chemicals, targeting molecules directly involved with the deterioration of adipocyte metabolism, may restore proper functionality of these cells and restore adipose tissue homeostasis
Summary
Protein tyrosine phosphatase 1B (PTP1B) is one of the major negative regulators of leptin and insulin signaling, and has been strongly implicated in insulin resistance development in the course of obesity and metabolic syndrome conditions; its exact role in controlling adipose tissue biogenesis is still poorly understood. Metabolic syndrome in both human as well as in horses (defined as equine metabolic syndrome—EMS) has become more and more frequently diagnosed endocrine disorder [1, 2]. Obesity is not a critical component of EMS, since it was proved that lean horses suffer for insulin resistance, involvement of adipose tissue deterioration in EMS and local inflammation seem to be indisputable [4,5,6]
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have